• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bioinformatics and variability in drug response: a protein structural perspective.生物信息学与药物反应的变异性:从蛋白质结构角度看。
J R Soc Interface. 2012 Jul 7;9(72):1409-37. doi: 10.1098/rsif.2011.0843. Epub 2012 May 2.
2
Application of graph-based analysis of genomic sequence context for characterization of drug targets.基于图的基因组序列上下文分析在药物靶点表征中的应用。
Curr Drug Discov Technol. 2006 Sep;3(3):175-88. doi: 10.2174/157016306780136808.
3
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
4
Inferring protein domains associated with drug side effects based on drug-target interaction network.基于药物-靶点相互作用网络推断与药物副作用相关的蛋白质结构域
BMC Syst Biol. 2013;7 Suppl 6(Suppl 6):S18. doi: 10.1186/1752-0509-7-S6-S18. Epub 2013 Dec 13.
5
Combinations of protein-chemical complex structures reveal new targets for established drugs.蛋白质-化学复合物结构的组合揭示了已有药物的新靶点。
PLoS Comput Biol. 2011 May;7(5):e1002043. doi: 10.1371/journal.pcbi.1002043. Epub 2011 May 5.
6
Chemical-protein interactome and its application in off-target identification.化学蛋白质相互作用组及其在脱靶识别中的应用。
Interdiscip Sci. 2011 Mar;3(1):22-30. doi: 10.1007/s12539-011-0051-8. Epub 2011 Mar 3.
7
The utility of structural biology in drug discovery.结构生物学在药物发现中的应用。
Methods Mol Biol. 2012;841:1-27. doi: 10.1007/978-1-61779-520-6_1.
8
Impact of germline and somatic missense variations on drug binding sites.种系和体细胞错义变异对药物结合位点的影响。
Pharmacogenomics J. 2017 Mar;17(2):128-136. doi: 10.1038/tpj.2015.97. Epub 2016 Jan 26.
9
Drug-Target Interaction Prediction with Graph Regularized Matrix Factorization.基于图正则化矩阵分解的药物-靶点相互作用预测
IEEE/ACM Trans Comput Biol Bioinform. 2017 May-Jun;14(3):646-656. doi: 10.1109/TCBB.2016.2530062. Epub 2016 Feb 15.
10
A large-scale computational approach to drug repositioning.一种用于药物重新定位的大规模计算方法。
Genome Inform. 2006;17(2):239-47.

引用本文的文献

1
A comprehensive machine learning for high throughput Tuberculosis sequence analysis, functional annotation, and visualization.一种用于高通量结核病序列分析、功能注释和可视化的综合机器学习方法。
Sci Rep. 2025 Jul 16;15(1):25866. doi: 10.1038/s41598-025-98654-0.
2
Computational investigation of stigmasterol as a potential therapeutic agent for cervical cancer: insights from density functional theory (DFT) and molecular docking studies.豆甾醇作为宫颈癌潜在治疗剂的计算研究:来自密度泛函理论(DFT)和分子对接研究的见解
In Silico Pharmacol. 2025 May 24;13(2):77. doi: 10.1007/s40203-025-00361-1. eCollection 2025.
3
Fritillaria steroidal alkaloids and their multi-target therapeutic mechanisms: insights from network pharmacology.浙贝母甾体生物碱及其多靶点治疗机制:基于网络药理学的见解
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2209-2228. doi: 10.1007/s00210-024-03502-z. Epub 2024 Oct 9.
4
Structural and Phylogenetic Analysis of Protein Reveals New Insights into Its Role in Emerging and Re-Emerging Diseases in Mammals.蛋白质的结构与系统发育分析揭示了其在哺乳动物新出现和再次出现疾病中的作用的新见解。
Vaccines (Basel). 2023 Mar 16;11(3):671. doi: 10.3390/vaccines11030671.
5
PSnpBind-ML: predicting the effect of binding site mutations on protein-ligand binding affinity.PSnpBind-ML:预测结合位点突变对蛋白质-配体结合亲和力的影响。
J Cheminform. 2023 Mar 2;15(1):31. doi: 10.1186/s13321-023-00701-3.
6
First report of computational protein-ligand docking to evaluate susceptibility to HIV integrase inhibitors in HIV-infected Iranian patients.关于通过计算蛋白-配体对接评估伊朗HIV感染患者对HIV整合酶抑制剂敏感性的首次报告。
Biochem Biophys Rep. 2022 Mar 29;30:101254. doi: 10.1016/j.bbrep.2022.101254. eCollection 2022 Jul.
7
Analysis of the Biochemical Reaction Status by Real-Time Monitoring Molecular Diffusion Behaviors Using a Transistor Biosensor Integrated with a Microfluidic Channel.使用集成微流控通道的晶体管生物传感器通过实时监测分子扩散行为分析生化反应状态。
ACS Omega. 2021 Apr 2;6(18):11911-11917. doi: 10.1021/acsomega.1c00222. eCollection 2021 May 11.
8
Structural Comparison of Diverse HIV-1 Subtypes using Molecular Modelling and Docking Analyses of Integrase Inhibitors.利用分子建模和整合酶抑制剂对接分析对不同 HIV-1 亚型进行结构比较。
Viruses. 2020 Aug 26;12(9):936. doi: 10.3390/v12090936.
9
Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21.肽/受体协同进化解释了神经肽 TLQP-21 的脂肪分解功能。
Cell Rep. 2019 Sep 3;28(10):2567-2580.e6. doi: 10.1016/j.celrep.2019.07.101.
10
Simultaneous Binding of Folic Acid and Methotrexate to Human Serum Albumin: Insights into the Structural Changes of Protein and the Location and Competitive Displacement of Drugs.叶酸和甲氨蝶呤与人血清白蛋白的同时结合:对蛋白质结构变化以及药物位置和竞争性置换的深入了解。
ACS Omega. 2018 Jan 31;3(1):246-253. doi: 10.1021/acsomega.7b01437. Epub 2018 Jan 9.

本文引用的文献

1
All-atom empirical potential for molecular modeling and dynamics studies of proteins.蛋白质分子建模和动力学研究的全原子经验势。
J Phys Chem B. 1998 Apr 30;102(18):3586-616. doi: 10.1021/jp973084f.
2
Ab initio protein structure assembly using continuous structure fragments and optimized knowledge-based force field.从头开始使用连续结构片段和优化的基于知识的力场进行蛋白质结构组装。
Proteins. 2012 Jul;80(7):1715-35. doi: 10.1002/prot.24065. Epub 2012 Apr 13.
3
Bioinformatics for personal genome interpretation.个人基因组解读的生物信息学。
Brief Bioinform. 2012 Jul;13(4):495-512. doi: 10.1093/bib/bbr070. Epub 2012 Jan 13.
4
Using multiple microenvironments to find similar ligand-binding sites: application to kinase inhibitor binding.利用多种微环境寻找相似的配体结合位点:在激酶抑制剂结合中的应用。
PLoS Comput Biol. 2011 Dec;7(12):e1002326. doi: 10.1371/journal.pcbi.1002326. Epub 2011 Dec 29.
5
Optimized torsion-angle normal modes reproduce conformational changes more accurately than cartesian modes.优化的扭转角振动模式比笛卡尔模式更能准确地再现构象变化。
Biophys J. 2011 Dec 21;101(12):2966-9. doi: 10.1016/j.bpj.2011.10.054. Epub 2011 Dec 20.
6
Let's get honest about sampling.让我们坦诚地谈谈抽样问题。
J Comput Aided Mol Des. 2012 Jan;26(1):93-5. doi: 10.1007/s10822-011-9497-y. Epub 2011 Nov 24.
7
Automated protein structure modeling in CASP9 by I-TASSER pipeline combined with QUARK-based ab initio folding and FG-MD-based structure refinement.CASP9 中通过 I-TASSER 流水线结合 QUARK 基于从头折叠和 FG-MD 基于结构精修的自动化蛋白质结构建模。
Proteins. 2011;79 Suppl 10(Suppl 10):147-60. doi: 10.1002/prot.23111. Epub 2011 Aug 23.
8
Investigation by site-directed mutagenesis of the role of cytochrome P450 2B4 non-active-site residues in protein-ligand interactions based on crystal structures of the ligand-bound enzyme.基于配体结合酶的晶体结构,通过定点突变研究细胞色素 P450 2B4 非活性部位残基在蛋白质-配体相互作用中的作用。
FEBS J. 2012 May;279(9):1607-20. doi: 10.1111/j.1742-4658.2011.08411.x. Epub 2011 Nov 25.
9
Mechanism of the hydrophobic effect in the biomolecular recognition of arylsulfonamides by carbonic anhydrase.碳酸酐酶识别芳基磺酰胺类生物分子的疏水作用机制。
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):17889-94. doi: 10.1073/pnas.1114107108. Epub 2011 Oct 19.
10
Assessment of template based protein structure predictions in CASP9.评估基于模板的蛋白质结构预测在 CASP9 中的表现。
Proteins. 2011;79 Suppl 10:37-58. doi: 10.1002/prot.23177. Epub 2011 Oct 15.

生物信息学与药物反应的变异性:从蛋白质结构角度看。

Bioinformatics and variability in drug response: a protein structural perspective.

机构信息

Department of Bioengineering, Stanford University, Stanford, CA, USA.

出版信息

J R Soc Interface. 2012 Jul 7;9(72):1409-37. doi: 10.1098/rsif.2011.0843. Epub 2012 May 2.

DOI:10.1098/rsif.2011.0843
PMID:22552919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3367825/
Abstract

Marketed drugs frequently perform worse in clinical practice than in the clinical trials on which their approval is based. Many therapeutic compounds are ineffective for a large subpopulation of patients to whom they are prescribed; worse, a significant fraction of patients experience adverse effects more severe than anticipated. The unacceptable risk-benefit profile for many drugs mandates a paradigm shift towards personalized medicine. However, prior to adoption of patient-specific approaches, it is useful to understand the molecular details underlying variable drug response among diverse patient populations. Over the past decade, progress in structural genomics led to an explosion of available three-dimensional structures of drug target proteins while efforts in pharmacogenetics offered insights into polymorphisms correlated with differential therapeutic outcomes. Together these advances provide the opportunity to examine how altered protein structures arising from genetic differences affect protein-drug interactions and, ultimately, drug response. In this review, we first summarize structural characteristics of protein targets and common mechanisms of drug interactions. Next, we describe the impact of coding mutations on protein structures and drug response. Finally, we highlight tools for analysing protein structures and protein-drug interactions and discuss their application for understanding altered drug responses associated with protein structural variants.

摘要

市售药物在临床实践中的表现常常不如其获批所依据的临床试验。许多治疗性化合物对大量被处方的患者群体无效;更糟糕的是,相当一部分患者出现了比预期更严重的不良反应。许多药物不可接受的风险效益比要求向个体化医学范式转变。然而,在采用个体化方法之前,了解不同患者群体中药物反应差异的分子细节是很有用的。在过去的十年中,结构基因组学的进展导致了可用的药物靶蛋白三维结构的爆炸式增长,而药物遗传学的努力则提供了与不同治疗结果相关的多态性的见解。这些进展共同提供了机会来研究由于遗传差异而产生的改变的蛋白质结构如何影响蛋白质-药物相互作用,并最终影响药物反应。在这篇综述中,我们首先总结了蛋白质靶标的结构特征和药物相互作用的常见机制。接下来,我们描述了编码突变对蛋白质结构和药物反应的影响。最后,我们强调了分析蛋白质结构和蛋白质-药物相互作用的工具,并讨论了它们在理解与蛋白质结构变体相关的改变的药物反应方面的应用。